Improving Patient Outcomes and Early Diagnosis: An Examination of the REVEAL Registry
November 10, 2011
Listen as five of the nation's leading pulmonary arterial hypertension (PAH) physicians present groundbreaking data from the REVEAL Registry about trends in PAH patient care. This research suggests that despite a range of available therapies, patients in the United States still experience significant delays in diagnosis. Panelists discuss the need for early diagnosis of PAH and more of the latest research recommendations to improve patient outcomes.
This Pulmonary Hypertension (PH) Awareness Month webinar was hosted as part of a partnership between the Pulmonary Hypertension Association and the American Thoracic Society in recognition of Pulmonary Hypertension Week at the ATS.
The REVEAL Registry is a multicenter, observational research study of PAH patients. Over 3,500 patients are enrolled in the U.S.-based registry, making it the largest PAH study in the world.